Back to Results
First PageMeta Content
Pandemics / Vaccines / Pharmacology / Acetamides / Neuraminidase inhibitors / Oseltamivir / Adverse effect / Pharmacovigilance / FluMist / Health / Medicine / Influenza


Guidelines for Reporting of Suspected Adverse Reactions to Antivirals During an Influenza Pandemic
Add to Reading List

Document Date: 2013-07-09 12:42:37


Open Document

File Size: 115,68 KB

Share Result on Facebook

City

Edmonton / Halifax / West Montréal / Toronto / Saskatoon / Burnaby / Lagimodière Blvd Winnipeg / /

Company

Canada Vigilance Program / Health Professionals / /

Country

Canada / /

/

Event

FDA Phase / /

Facility

East Tower / /

IndustryTerm

health product / health products / Online Database / natural health products / /

MedicalCondition

pandemic influenza virus / birth defect / influenza virus / illness / influenza / pneumonia / influenza infection / influenza A / pandemic influenza / flu virus / infection / /

NaturalFeature

Edward Island / /

Organization

appropriate Canada Vigilance Regional Office / Public Health Agency of Canada Web / Canada Vigilance Regional Office / /

/

Product

Tamiflu / Antiviral Drugs / Relenza / MedEffectTM Canada Table / /

ProvinceOrState

Alberta / Northwest Territories / Quebec / New Brunswick / Saskatchewan / Prince Edward Island / Nunavut / Newfoundland / British Columbia / Manitoba / Nova Scotia / Ontario / /

RadioStation

5 What / 3 What / /

Technology

antibodies / /

URL

www.fightflu.ca / www.health.gc.ca/medeffect / /

SocialTag